Literature DB >> 12919966

Anti-inflammatory drugs and Alzheimer's disease.

Christopher Martyn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12919966      PMCID： PMC1126777          DOI： 10.1136/bmj.327.7411.353

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.

Authors:  S Weggen; J L Eriksen; P Das; S A Sagi; R Wang; C U Pietrzik; K A Findlay; T E Smith; M P Murphy; T Bulter; D E Kang; N Marquez-Sterling; T E Golde; E H Koo
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

2.  Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.

Authors:  B A in t' Veld; A Ruitenberg; A Hofman; L J Launer; C M van Duijn; T Stijnen; M M Breteler; B H Stricker
Journal:  N Engl J Med       Date:  2001-11-22       Impact factor: 91.245

Review 3.  Alzheimer's disease and Parkinson's disease.

Authors:  Robert L Nussbaum; Christopher E Ellis
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

Review 4.  Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies.

Authors:  Mahyar Etminan; Sudeep Gill; Ali Samii
Journal:  BMJ       Date:  2003-07-19

Review 5.  Inflammation and therapeutic vaccination in CNS diseases.

Authors:  Howard L Weiner; Dennis J Selkoe
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

6.  Anti-inflammatory drugs and Alzheimer disease.

Authors:  P L McGeer; E McGeer; J Rogers; J Sibley
Journal:  Lancet       Date:  1990-04-28       Impact factor: 79.321

Review 7.  Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease.

Authors:  N C Inestrosa; M P Marzolo; A B Bonnefont
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

8.  Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Stephen R Rapp; Mark A Espeland; Sally A Shumaker; Victor W Henderson; Robert L Brunner; JoAnn E Manson; Margery L S Gass; Marcia L Stefanick; Dorothy S Lane; Jennifer Hays; Karen C Johnson; Laura H Coker; Maggie Dailey; Deborah Bowen
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

9.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

10.  Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

Authors:  Paul S Aisen; Kimberly A Schafer; Michael Grundman; Eric Pfeiffer; Mary Sano; Kenneth L Davis; Martin R Farlow; Shelia Jin; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272
  10 in total
  4 in total

1.  Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer's disease.

Authors:  Elham Nasiri; Roman Sankowski; Henriette Dietrich; Aikaterini Oikonomidi; Patricio T Huerta; Julius Popp; Yousef Al-Abed; Michael Bacher
Journal:  Mol Med       Date:  2020-04-17       Impact factor: 6.354

2.  Intermittent hypoxia treatment alleviates memory impairment in the 6-month-old APPswe/PS1dE9 mice and reduces amyloid beta accumulation and inflammation in the brain.

Authors:  Xiangpei Yue; Yanzhao Zhou; Meng Qiao; Xingnan Zhao; Xin Huang; Tong Zhao; Xiang Cheng; Ming Fan; Yongqi Zhao; Ruoli Chen; Lingling Zhu
Journal:  Alzheimers Res Ther       Date:  2021-11-29       Impact factor: 6.982

Review 3.  Inflammatory Cascade in Alzheimer's Disease Pathogenesis: A Review of Experimental Findings.

Authors:  Jade de Oliveira; Ewa Kucharska; Michelle Lima Garcez; Matheus Scarpatto Rodrigues; João Quevedo; Ines Moreno-Gonzalez; Josiane Budni
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

4.  Treatment with TNF-α inhibitors versus methotrexate and the association with dementia and Alzheimer's disease.

Authors:  David M Kern; Simon Lovestone; M Soledad Cepeda
Journal:  Alzheimers Dement (N Y)       Date:  2021-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.